Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Equity Ratio: 2017-2019

Historic Equity Ratio for Astria Therapeutics (ATXS) over the last 3 years, with Sep 2019 value amounting to 0.87.

  • Astria Therapeutics' Equity Ratio fell 3.68% to 0.87 in Q3 2019 from the same period last year, while for Sep 2019 it was 0.87, marking a year-over-year decrease of 3.68%. This contributed to the annual value of 0.89 for FY2018, which is 35.39% up from last year.
  • Per Astria Therapeutics' latest filing, its Equity Ratio stood at 0.87 for Q3 2019, which was down 2.28% from 0.89 recorded in Q2 2019.
  • Astria Therapeutics' Equity Ratio's 5-year high stood at 0.92 during Q1 2019, with a 5-year trough of 0.66 in Q4 2017.
  • In the last 3 years, Astria Therapeutics' Equity Ratio had a median value of 0.87 in 2019 and averaged 0.80.
  • As far as peak fluctuations go, Astria Therapeutics' Equity Ratio soared by 35.39% in 2018, and later fell by 3.68% in 2019.
  • Over the past 3 years, Astria Therapeutics' Equity Ratio (Quarterly) stood at 0.66 in 2017, then skyrocketed by 35.39% to 0.89 in 2018, then fell by 3.68% to 0.87 in 2019.
  • Its Equity Ratio was 0.87 in Q3 2019, compared to 0.89 in Q2 2019 and 0.92 in Q1 2019.